NowPatient vs Priority Meds
An in-depth comparison of two leading GLP-1 Providers
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
NowPatient
Best for Brand-name GLP-1 access without a compounded routeStarting at $1069/mo
Priority Meds
Best for pending product verificationStarting at $113/mo
Side-by-Side Comparison
| Feature | NowPatient | Priority Meds |
|---|---|---|
| Overall Score | 6.8/10 | ✓7.1/10 |
| Starting Price | $1069/mo | ✓$113/mo |
| Editorial Rating | 3.4 ★ /5 | ✓3.6 ★ /5 |
| Features | 2 features | ✓4 features |
| States Available | 0 | 0 |
| Compounded | — | ✓ Yes |
| Brand Name | ✓ Yes | — |
| FSA/HSA Accepted | — | — |
| FDA Warnings | None | None |
Pros & Cons
NowPatient
Pros
- ✓Free telehealth consultation — patients only pay the medication cost
- ✓Brand-name Mounjaro, Wegovy injection, Wegovy oral tablet, and Saxenda all available
- ✓One of the few telehealth platforms offering Wegovy in both injection and oral pill form
- ✓No compounded options — every drug is FDA-approved brand
Cons
- ✗Cash-pay pricing tracks full brand list price (~$1,000-$1,350/mo)
- ✗Does not offer compounded semaglutide or tirzepatide (generally the cheaper route)
- ✗State availability not disclosed publicly — determined during intake
- ✗Phone: 1-866-967-1977, HQ Austin TX
- ✗Does NOT offer Foundayo (orforglipron)
Priority Meds
Pros
- ✓Flat-dose pricing (no dose-escalation increases) per competitor sources
- ✓B-vitamin co-compounding (sema+B12, tirz+B6) is a differentiator in the segment
- ✓Clearwater FL based US operation
Cons
- ✗Stub entry — exact drug formulary, pricing tiers, states served, and pharmacy partners need a YMYL verification pass
- ✗Confidence is LOW until that pass is done
Our Verdict
Priority Meds edges out NowPatient with a higher overall score of 7.1/10 and is particularly strong for pending product verification. NowPatient remains a solid alternative, especially if you're looking for Brand-name GLP-1 access without a compounded route.
Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.